How to buy Interpace Biosciences stock (IDXG)

Interpace Biosciences is a diagnostics & research business based in the US. Interpace Biosciences shares (IDXG) are listed on the OTCQX (a marketplace for buying and selling "over the counter" stocks which aren't listed on a formal stock exchange) and all prices are listed in US Dollars. Its last market close was $2.83 – an increase of 2.72% over the previous week. Interpace Biosciences employs 108 staff and has a trailing 12-month revenue of around $44.9 million.

Our top picks for where to buy Interpace Biosciences stock

Buy Interpace Biosciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Interpace Biosciences stock price (OTCQX: IDXG)

Use our graph to track the performance of IDXG stocks over time.

Interpace Biosciences shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$2.83
52-week range	$0.78 - $3.54
50-day moving average more info button	$2.73
200-day moving average more info button	$2.02
Wall St. target price	$11.00
PE ratio more info button	2.1909
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$1.10

Is it a good time to buy Interpace Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Interpace Biosciences price performance over time

Historical closes compared with the close of $2.84 from 2024-12-20

1 week (2024-12-17)	3.09%
1 month (2024-11-22)	6.77%
3 months (2024-09-24)	67.06%
6 months (2024-06-24)	131.70%

1 year (2023-12-22)	222.73%
2 years (2022-12-23)	278.67%
3 years (2021-12-23)	7.1001
5 years (2019-12-24)	4.929

Is Interpace Biosciences stock undervalued or overvalued?

Valuing Interpace Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Interpace Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Interpace Biosciences's P/E ratio

Interpace Biosciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Interpace Biosciences shares trade at around 2x recent earnings.

Interpace Biosciences's EBITDA

Interpace Biosciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.6 million.

The EBITDA is a measure of a Interpace Biosciences's overall financial performance and is widely used to measure a its profitability.

Interpace Biosciences financials

Revenue TTM	$44.9 million
Operating margin TTM	15.49%
Gross profit TTM	$18.2 million
Return on assets TTM	28.09%
Return on equity TTM	-284.81%
Profit margin	10.47%
Book value	$-13.13
Market Capitalization more info button	$10.6 million

TTM: trailing 12 months

Interpace Biosciences share dividends

We're not expecting Interpace Biosciences to pay a dividend over the next 12 months.

Have Interpace Biosciences's shares ever split?

Interpace Biosciences's shares were split on a 1:10 basis on 14 January 2020 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Interpace Biosciences shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Interpace Biosciences shares which in turn could have impacted Interpace Biosciences's share price.

Interpace Biosciences share price volatility

Over the last 12 months, Interpace Biosciences's shares have ranged in value from as little as $0.78 up to $3.54. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (OTCQX average) beta is 1, while Interpace Biosciences's is 0.625. This would suggest that Interpace Biosciences's shares are less volatile than average (for this exchange).

Interpace Biosciences overview

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test for the diagnosis and prognosis of pancreatic cancer; PanDNA, a molecular only version of PancraGEN; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company primarily serves physicians, cancer center, clinics, laboratories, pathology groups, and hospitals. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc.

Frequently asked questions

null
What percentage of Interpace Biosciences is owned by insiders?
Currently 26.416% of Interpace Biosciences shares are held by insiders. How many people work for Interpace Biosciences?
Latest data suggests 108 work at Interpace Biosciences. When does the fiscal year end for Interpace Biosciences?
Interpace Biosciences's fiscal year ends in December. Where is Interpace Biosciences based?
Interpace Biosciences's address is: Waterview Plaza, Parsippany, NJ, United States, 07054 What is Interpace Biosciences's ISIN number?
Interpace Biosciences's international securities identification number is: US46062X3035 What is Interpace Biosciences's CUSIP number?
Interpace Biosciences's Committee on Uniform Securities Identification Procedures number is: 74312N107